The Home Depot, Inc. <HD.N>: UBS Cuts Target Price to $420 From $430
HD•Related News
Fortitude Invests $1.0 Million In HeartSciences At A 22% Premium With No Adjustment To The Merger Consideration
HSCS•
Revelation Biosciences names Avance Clinical as CRO for Phase 2/3 Gemini AKI trial
REVB•
Centrus Energy Corp. <LEU.N>: UBS Raises Target Price to $185 From $170
LEU•
Scinai Immunotherapeutics changes ADS ratio in move equivalent to 1-for-10 reverse split
SCNI•
AE Industrial Partners names Air Lease co-founder John Plueger senior advisor
AL•